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Bilateral Adrenal Hemorrhage in a Patient with 
Antiphospholipid Syndrome
Silpa Yalamanchili, MD
INTRODUCTION
Bilateral adrenal hemorrhage is relatively uncommon, 
with a reported incidence in the United States of 0.3-1.8% 
in hospital post-mortems1.Clinical manifestations of 
adrenal hemorrhage are widely variable, making diagnosis 
a challenge. Left undiagnosed and untreated, bilateral 
adrenal hemorrhage may lead to cardiovascular collapse 
and/or death. Here we present a rare case of bilateral 
adrenal hemorrhage in a patient with antiphospholipid 
syndrome; the aim of this case, and the corresponding 
literature review, is to highlight risk factors for and 
management of this condition. 
CASE PRESENTATION
A 50-year-old woman with recent bilateral knee 
replacements developed crampy, diffuse abdominal pain 
for two days. The pain was associated with subjective 
fevers, nausea, and one episode of non-bloody emesis. 
A CT of the abdomen and pelvis done at an outside 
facility showed no abnormalities. Due to persistent 
symptoms for two days, the patient returned to the 
emergency department for evaluation. Her co-morbidities 
included antiphospholipid syndrome, prior deep vein 
thromboses and pulmonary embolism, recent IVC filter 
placement, lupus, and hypertension. She was receiving 
maintenance anticoagulation with warfarin for her history 
of thromboses with goal INR of 2-3, however admission 
labs revealed an INR of 6.61. Initial vitals were significant 
for a fever of 100.7ºF,  heart rate of 124, and blood 
pressure of110/71. Physical examination revealed diffuse 
tenderness to palpation on abdominal exam with normal 
bowel sounds. No rebound, guarding, flank bruising, or 
costovertebral angle tenderness was noted. Admission 
labs showed WBC 12.4, Hb 10.8, Plt 68, INR 6.61, Na 124, 
K 3.4. Repeat CT of the abdomen and pelvis showed 
hyperdensities in both adrenal glands concerning for 
bilateral adrenal hemorrhage (Figure 1).
The patient’s warfarin was reversed with Vitamin K 2.5mg 
PO as well as Vitamin K 2mg IV, and four units of fresh 
frozen plasma. Due to concerns about the development 
of adrenal insufficiency, she was started on Hydrocortisone 
50mg IV q8hr. The patient was managed supportively, 
with no surgical intervention. Her hemoglobin was serially 
monitored, and she did not require any blood transfusions. 
Due to the patient’s high risk of thrombosis from antiphos-
pholipid syndrome, she was restarted on therapeutic 
anticoagulation as soon as she was deemed stable from 
a bleeding perspective. Repeat CT scans showed no 
continued bleeding. The patient’s subsequent hospital 
course was complicated by thrombocytopenia, septic 
shock requiring intubation, ventricular fibrillation cardiac 
arrest, and Takutsubo cardiomyopathy. The patient 
ultimately recovered after a 28-day hospital stay and was 
sent home on a taper of hydrocortisone with instructions 
to follow up with hematology and endocrinology. She 
was to obtain an outpatient CT abdomen/pelvis four 
weeks after discharge to evaluate for resolution of 
hemorrhage, however the patient was lost to follow up.
DISCUSSION
Bilateral adrenal hemorrhage is a rare but potentially fatal 
condition. Existing literature suggests that bilateral adrenal 
hemorrhage occurs at an incidence of 4.7-6.2 per million 
in developed countries.2 However, inadequate detection 
and vague clinical presentation often prevents appropriate 
and timely management of this condition. 
The exact pathophysiology of adrenal hemorrhage is not 
well understood, but case reports suggest that it may 
represent a multifactorial etiology. The first theory of the 
development of adrenal hemorrhage relates to the 
adrenal blood supply. Each adrenal gland is supplied by 
50-60 arterioles, which drain into the medullary sinusoids 
via relatively few venous channels. Each adrenal gland is 
drained by a single central vein, composed of thick 
longitudinal muscle, creating increased resistance to flow. 
During periods of stress, ACTH hormone is released, 
causing an influx of blood flow to the adrenal glands 
which may exceed the ability of the singular adrenal vein 
ENDOCRINOLOGY
Figure 1. Both adrenal glands are enlarged, oval in shape, and relatively hyperdense. 
There is surrounding periadrenal fat stranding bilaterally, more extensive on the left.
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to adequately drain. This may lead to hemorrhage of the 
capillaries at the cortico-medullary junction. A second 
theory relates to the effect of circulating catecholamines 
on the adrenal glands. Catecholamine surge promotes 
vasoconstriction and platelet aggregation, which may 
induce vasospasm and hemorrhage of the fragile capillary 
vessels. A final theory connects adrenal hemorrhage to 
arterial thrombosis. Some evidence suggests that the 
adrenal vessels are prone to the development of platelet 
thrombi and stasis during periods of catecholamine surge. 
This outflow obstruction may result in hemorrhage of the 
capillary vessels.1 This final theory may account for the 
association between antiphospholipid syndrome and 
adrenal hemorrhage, and may be the underlying etiology 
of hemorrhage in the patient presented in this case report.
The potential causes of adrenal hemorrhage are vast. 
Approximately half of all reported cases are associated 
with a stressful event or illness. Sepsis, infection, surgery, 
blunt trauma, myocardial infarction, heart failure 
exacerbation, and pregnancy complications have all been 
implicated as precipitants of adrenal hemorrhage. There 
is an increased risk in patients on anticoagulation; more 
commonly with patients on heparin.3 Thromboembolic 
diseases, such as antiphospholipid syndrome or heparin 
induced thrombocytopenia, can potentiate the risk of 
adrenal hemorrhage as well.4  The patient in this report 
presumably developed adrenal hemorrhage as a result of 
antiphospholipid syndrome in the setting of a suprathera-
peutic INR, complicated by sepsis. Less common causes 
of adrenal hemorrhage include tuberculosis, amyloidosis, 
and metastatic tumors to the adrenal glands.
The most concerning complication of bilateral adrenal 
hemorrhage is the development of acute adrenal 
insufficiency. If left untreated, adrenal crisis may lead to 
critical illness and death. Clinical manifestations of adrenal 
insufficiency are typically not noted until 90% of the 
adrenal cortex has been destroyed, and insufficiency 
does not typically develop in unilateral adrenal 
hemorrhage. Death in bilateral adrenal hemorrhage more 
often occurs due to the underling precipitating condition 
rather than due to the hemorrhage itself, with a mortality 
rate as high as 15%.4
Presentation of adrenal hemorrhage is highly variable and 
often vague. In 65-85% of published cases, the most 
common complaint was nonspecific pain. Pain has been 
reported in the epigastrium, flanks, upper and lower back, 
pelvis, precordium, and thorax, highlighting the diagnostic 
challenge in identifying this condition. Some patients may 
present with fatigue, dizziness, arthralgias, anorexia, 
nausea, and vomiting, which may be moreso related to 
the development of adrenal insufficiency than due to 
hemorrhage itself. The most common physical exam 
findings associated with adrenal hemorrhage are fever, 
tachycardia, and orthostatic hypotension. In rare cases of 
meningococcal infection, adrenal insufficiency may 
develop as a component of Waterhouse Friderichsen 
syndrome, with an associated maculopapular rash. 
Approximately 15-20% of patients show signs of acute 
abdomen related to hemorrhage. An estimated 20-40% 
of patients may exhibit altered mental status, related to 
underlying disease or development of adrenal 
insufficiency.1 
Workup of adrenal hemorrhage and associated adrenal 
insufficiency is limited. As with any bleeding event, serial 
hemoglobin monitoring must be performed to screen for 
persistent bleeding. A basic metabolic panel may reveal 
hyponatremia, hyperkalemia, and prerenal azotemia, 
suggesting the presence of adrenal insufficiency. The 
absence of these characteristics should not exclude a 
diagnosis of adrenal insufficiency in an acutely ill patient 
with bilateral adrenal hemorrhage. A baseline cortisol 
level may be obtained to stratify patients suspected to 
have adrenal insufficiency, or patients requiring additional 
cosyntropin stimulation testing. The imaging of choice 
for adrenal hemorrhage is CT of the abdomen and pelvis 
without contrast. Evidence of adrenal hemorrhage is 
evident in areas of higher attenuation (50-60 Hounsfield 
units), possibly with surrounding fat stranding or signs of 
inflammation. In a patient with confirmed bilateral adrenal 
hemorrhage and suspected adrenal insufficiency, 
treatment with stress-dosed steroids should not be 
delayed while waiting for the results of laboratory testing. 
Treatment of bilateral adrenal hemorrhage is directed at 
treatment of the hemorrhage itself, and of any resulting 
adrenal insufficiency. In the 1990’s, most patients with 
adrenal hemorrhage received surgery (adrenalectomies, 
adrenal repairs). Current literature endorses supportive 
therapy as the mainstay for patients with hemorrhage, as 
better outcomes have been observed in patients who do 
not undergo surgery.4 This includes serial hemoglobin 
measurements, blood transfusions as needed, and fluid 
and electrolyte resuscitation. Current recommendations 
dictate that if there are no other indications for exploratory 
surgery in a trauma patient with adrenal insufficiency, 
supportive therapy is preferred if bleeding has stabilized. If 
persistent bleeding occurs, patients should be sent for 
embolization rather than open surgery. It is imperative to 
follow these patients with serial CT imaging to verify 
resolution of adrenal hematomas. No absolute recommen-
dations have been made regarding timing of repeat 
imaging. Steroid replacement should be initiated with 
Hydrocortisone IV 150mg-300mg in divided doses for a 
total of 2-3 days. After this period, therapy can be tapered 
as tolerated. At higher doses, Hydrocortisone has both 
mineralocorticoid and glucocorticoid effects, however, 
once the total daily dose of Hydrocortisone is decreased 
to 50mg, additional mineralocorticoid therapy should be 
given. Many patients recover some, if not all, adrenal 
function, and may only require steroid replacement for a 
finite length of time. An outpatient cosyntropin test should 
be obtained to evaluate for the recovery of adrenal 
function.
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